Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Androgen and Anabolic Steroid Market Growth 2022-2028

  • LP 4879823
  • 105 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Androgen and Anabolic Steroid will have significant change from previous year. According to our (LP Information) latest study, the global Androgen and Anabolic Steroid market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Androgen and Anabolic Steroid market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Androgen and Anabolic Steroid market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Androgen and Anabolic Steroid market, reaching US$ million by the year 2028. As for the Europe Androgen and Anabolic Steroid landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Androgen and Anabolic Steroid players cover Auxilium Pharmaceuticals, AbbVie, Teva, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Androgen and Anabolic Steroid market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Testosterone

Methyltestosterone

Fluoxymesterone

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospitals

Pharmacy

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Auxilium Pharmaceuticals

AbbVie

Teva

GlaxoSmithKline

Endo Pharmaceuticals

Pfizer

Acerus Pharmaceuticals

Antares Pharma

Amneal Pharmaceuticals

Solvay Pharmaceuticals

Bausch Health

Pharmacia and Upjohn

Upsher-Smith

Clarus Therapeutics

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Androgen and Anabolic Steroid Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Androgen and Anabolic Steroid by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Androgen and Anabolic Steroid by Country/Region, 2017, 2022 & 2028

2.2 Androgen and Anabolic Steroid Segment by Type

2.2.1 Testosterone

2.2.2 Methyltestosterone

2.2.3 Fluoxymesterone

2.2.4 Others

2.3 Androgen and Anabolic Steroid Sales by Type

2.3.1 Global Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)

2.3.2 Global Androgen and Anabolic Steroid Revenue and Market Share by Type (2017-2022)

2.3.3 Global Androgen and Anabolic Steroid Sale Price by Type (2017-2022)

2.4 Androgen and Anabolic Steroid Segment by Application

2.4.1 Hospitals

2.4.2 Pharmacy

2.4.3 Others

2.5 Androgen and Anabolic Steroid Sales by Application

2.5.1 Global Androgen and Anabolic Steroid Sale Market Share by Application (2017-2022)

2.5.2 Global Androgen and Anabolic Steroid Revenue and Market Share by Application (2017-2022)

2.5.3 Global Androgen and Anabolic Steroid Sale Price by Application (2017-2022)

3 Global Androgen and Anabolic Steroid by Company

3.1 Global Androgen and Anabolic Steroid Breakdown Data by Company

3.1.1 Global Androgen and Anabolic Steroid Annual Sales by Company (2020-2022)

3.1.2 Global Androgen and Anabolic Steroid Sales Market Share by Company (2020-2022)

3.2 Global Androgen and Anabolic Steroid Annual Revenue by Company (2020-2022)

3.2.1 Global Androgen and Anabolic Steroid Revenue by Company (2020-2022)

3.2.2 Global Androgen and Anabolic Steroid Revenue Market Share by Company (2020-2022)

3.3 Global Androgen and Anabolic Steroid Sale Price by Company

3.4 Key Manufacturers Androgen and Anabolic Steroid Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Androgen and Anabolic Steroid Product Location Distribution

3.4.2 Players Androgen and Anabolic Steroid Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Androgen and Anabolic Steroid by Geographic Region

4.1 World Historic Androgen and Anabolic Steroid Market Size by Geographic Region (2017-2022)

4.1.1 Global Androgen and Anabolic Steroid Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Androgen and Anabolic Steroid Annual Revenue by Geographic Region

4.2 World Historic Androgen and Anabolic Steroid Market Size by Country/Region (2017-2022)

4.2.1 Global Androgen and Anabolic Steroid Annual Sales by Country/Region (2017-2022)

4.2.2 Global Androgen and Anabolic Steroid Annual Revenue by Country/Region

4.3 Americas Androgen and Anabolic Steroid Sales Growth

4.4 APAC Androgen and Anabolic Steroid Sales Growth

4.5 Europe Androgen and Anabolic Steroid Sales Growth

4.6 Middle East & Africa Androgen and Anabolic Steroid Sales Growth

5 Americas

5.1 Americas Androgen and Anabolic Steroid Sales by Country

5.1.1 Americas Androgen and Anabolic Steroid Sales by Country (2017-2022)

5.1.2 Americas Androgen and Anabolic Steroid Revenue by Country (2017-2022)

5.2 Americas Androgen and Anabolic Steroid Sales by Type

5.3 Americas Androgen and Anabolic Steroid Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Androgen and Anabolic Steroid Sales by Region

6.1.1 APAC Androgen and Anabolic Steroid Sales by Region (2017-2022)

6.1.2 APAC Androgen and Anabolic Steroid Revenue by Region (2017-2022)

6.2 APAC Androgen and Anabolic Steroid Sales by Type

6.3 APAC Androgen and Anabolic Steroid Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Androgen and Anabolic Steroid by Country

7.1.1 Europe Androgen and Anabolic Steroid Sales by Country (2017-2022)

7.1.2 Europe Androgen and Anabolic Steroid Revenue by Country (2017-2022)

7.2 Europe Androgen and Anabolic Steroid Sales by Type

7.3 Europe Androgen and Anabolic Steroid Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Androgen and Anabolic Steroid by Country

8.1.1 Middle East & Africa Androgen and Anabolic Steroid Sales by Country (2017-2022)

8.1.2 Middle East & Africa Androgen and Anabolic Steroid Revenue by Country (2017-2022)

8.2 Middle East & Africa Androgen and Anabolic Steroid Sales by Type

8.3 Middle East & Africa Androgen and Anabolic Steroid Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Androgen and Anabolic Steroid

10.3 Manufacturing Process Analysis of Androgen and Anabolic Steroid

10.4 Industry Chain Structure of Androgen and Anabolic Steroid

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Androgen and Anabolic Steroid Distributors

11.3 Androgen and Anabolic Steroid Customer

12 World Forecast Review for Androgen and Anabolic Steroid by Geographic Region

12.1 Global Androgen and Anabolic Steroid Market Size Forecast by Region

12.1.1 Global Androgen and Anabolic Steroid Forecast by Region (2023-2028)

12.1.2 Global Androgen and Anabolic Steroid Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Androgen and Anabolic Steroid Forecast by Type

12.7 Global Androgen and Anabolic Steroid Forecast by Application

13 Key Players Analysis

13.1 Auxilium Pharmaceuticals

13.1.1 Auxilium Pharmaceuticals Company Information

13.1.2 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Offered

13.1.3 Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Auxilium Pharmaceuticals Main Business Overview

13.1.5 Auxilium Pharmaceuticals Latest Developments

13.2 AbbVie

13.2.1 AbbVie Company Information

13.2.2 AbbVie Androgen and Anabolic Steroid Product Offered

13.2.3 AbbVie Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AbbVie Main Business Overview

13.2.5 AbbVie Latest Developments

13.3 Teva

13.3.1 Teva Company Information

13.3.2 Teva Androgen and Anabolic Steroid Product Offered

13.3.3 Teva Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Teva Main Business Overview

13.3.5 Teva Latest Developments

13.4 GlaxoSmithKline

13.4.1 GlaxoSmithKline Company Information

13.4.2 GlaxoSmithKline Androgen and Anabolic Steroid Product Offered

13.4.3 GlaxoSmithKline Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 GlaxoSmithKline Main Business Overview

13.4.5 GlaxoSmithKline Latest Developments

13.5 Endo Pharmaceuticals

13.5.1 Endo Pharmaceuticals Company Information

13.5.2 Endo Pharmaceuticals Androgen and Anabolic Steroid Product Offered

13.5.3 Endo Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Endo Pharmaceuticals Main Business Overview

13.5.5 Endo Pharmaceuticals Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer Androgen and Anabolic Steroid Product Offered

13.6.3 Pfizer Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Acerus Pharmaceuticals

13.7.1 Acerus Pharmaceuticals Company Information

13.7.2 Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Offered

13.7.3 Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Acerus Pharmaceuticals Main Business Overview

13.7.5 Acerus Pharmaceuticals Latest Developments

13.8 Antares Pharma

13.8.1 Antares Pharma Company Information

13.8.2 Antares Pharma Androgen and Anabolic Steroid Product Offered

13.8.3 Antares Pharma Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Antares Pharma Main Business Overview

13.8.5 Antares Pharma Latest Developments

13.9 Amneal Pharmaceuticals

13.9.1 Amneal Pharmaceuticals Company Information

13.9.2 Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Offered

13.9.3 Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Amneal Pharmaceuticals Main Business Overview

13.9.5 Amneal Pharmaceuticals Latest Developments

13.10 Solvay Pharmaceuticals

13.10.1 Solvay Pharmaceuticals Company Information

13.10.2 Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Offered

13.10.3 Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Solvay Pharmaceuticals Main Business Overview

13.10.5 Solvay Pharmaceuticals Latest Developments

13.11 Bausch Health

13.11.1 Bausch Health Company Information

13.11.2 Bausch Health Androgen and Anabolic Steroid Product Offered

13.11.3 Bausch Health Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Bausch Health Main Business Overview

13.11.5 Bausch Health Latest Developments

13.12 Pharmacia and Upjohn

13.12.1 Pharmacia and Upjohn Company Information

13.12.2 Pharmacia and Upjohn Androgen and Anabolic Steroid Product Offered

13.12.3 Pharmacia and Upjohn Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Pharmacia and Upjohn Main Business Overview

13.12.5 Pharmacia and Upjohn Latest Developments

13.13 Upsher-Smith

13.13.1 Upsher-Smith Company Information

13.13.2 Upsher-Smith Androgen and Anabolic Steroid Product Offered

13.13.3 Upsher-Smith Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Upsher-Smith Main Business Overview

13.13.5 Upsher-Smith Latest Developments

13.14 Clarus Therapeutics

13.14.1 Clarus Therapeutics Company Information

13.14.2 Clarus Therapeutics Androgen and Anabolic Steroid Product Offered

13.14.3 Clarus Therapeutics Androgen and Anabolic Steroid Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Clarus Therapeutics Main Business Overview

13.14.5 Clarus Therapeutics Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Androgen and Anabolic Steroid Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Androgen and Anabolic Steroid Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Testosterone

Table 4. Major Players of Methyltestosterone

Table 5. Major Players of Fluoxymesterone

Table 6. Major Players of Others

Table 7. Global Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)

Table 8. Global Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)

Table 9. Global Androgen and Anabolic Steroid Revenue by Type (2017-2022) & ($ million)

Table 10. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2017-2022)

Table 11. Global Androgen and Anabolic Steroid Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)

Table 13. Global Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)

Table 14. Global Androgen and Anabolic Steroid Revenue by Application (2017-2022)

Table 15. Global Androgen and Anabolic Steroid Revenue Market Share by Application (2017-2022)

Table 16. Global Androgen and Anabolic Steroid Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Androgen and Anabolic Steroid Sales by Company (2020-2022) & (K Units)

Table 18. Global Androgen and Anabolic Steroid Sales Market Share by Company (2020-2022)

Table 19. Global Androgen and Anabolic Steroid Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Androgen and Anabolic Steroid Revenue Market Share by Company (2020-2022)

Table 21. Global Androgen and Anabolic Steroid Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Androgen and Anabolic Steroid Producing Area Distribution and Sales Area

Table 23. Players Androgen and Anabolic Steroid Products Offered

Table 24. Androgen and Anabolic Steroid Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Androgen and Anabolic Steroid Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Androgen and Anabolic Steroid Sales Market Share Geographic Region (2017-2022)

Table 29. Global Androgen and Anabolic Steroid Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Androgen and Anabolic Steroid Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Androgen and Anabolic Steroid Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Androgen and Anabolic Steroid Sales Market Share by Country/Region (2017-2022)

Table 33. Global Androgen and Anabolic Steroid Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Androgen and Anabolic Steroid Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Androgen and Anabolic Steroid Sales by Country (2017-2022) & (K Units)

Table 36. Americas Androgen and Anabolic Steroid Sales Market Share by Country (2017-2022)

Table 37. Americas Androgen and Anabolic Steroid Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Androgen and Anabolic Steroid Revenue Market Share by Country (2017-2022)

Table 39. Americas Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)

Table 40. Americas Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)

Table 41. Americas Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)

Table 42. Americas Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)

Table 43. APAC Androgen and Anabolic Steroid Sales by Region (2017-2022) & (K Units)

Table 44. APAC Androgen and Anabolic Steroid Sales Market Share by Region (2017-2022)

Table 45. APAC Androgen and Anabolic Steroid Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Androgen and Anabolic Steroid Revenue Market Share by Region (2017-2022)

Table 47. APAC Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)

Table 48. APAC Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)

Table 49. APAC Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)

Table 50. APAC Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)

Table 51. Europe Androgen and Anabolic Steroid Sales by Country (2017-2022) & (K Units)

Table 52. Europe Androgen and Anabolic Steroid Sales Market Share by Country (2017-2022)

Table 53. Europe Androgen and Anabolic Steroid Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Androgen and Anabolic Steroid Revenue Market Share by Country (2017-2022)

Table 55. Europe Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)

Table 56. Europe Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)

Table 57. Europe Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)

Table 58. Europe Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Androgen and Anabolic Steroid Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Androgen and Anabolic Steroid Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Androgen and Anabolic Steroid Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Androgen and Anabolic Steroid Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Androgen and Anabolic Steroid Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Androgen and Anabolic Steroid

Table 68. Key Market Challenges & Risks of Androgen and Anabolic Steroid

Table 69. Key Industry Trends of Androgen and Anabolic Steroid

Table 70. Androgen and Anabolic Steroid Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Androgen and Anabolic Steroid Distributors List

Table 73. Androgen and Anabolic Steroid Customer List

Table 74. Global Androgen and Anabolic Steroid Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Androgen and Anabolic Steroid Sales Market Forecast by Region

Table 76. Global Androgen and Anabolic Steroid Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Androgen and Anabolic Steroid Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Androgen and Anabolic Steroid Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Androgen and Anabolic Steroid Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Androgen and Anabolic Steroid Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Androgen and Anabolic Steroid Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Androgen and Anabolic Steroid Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Androgen and Anabolic Steroid Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Androgen and Anabolic Steroid Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Androgen and Anabolic Steroid Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Androgen and Anabolic Steroid Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Androgen and Anabolic Steroid Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Androgen and Anabolic Steroid Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Androgen and Anabolic Steroid Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Androgen and Anabolic Steroid Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Androgen and Anabolic Steroid Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Androgen and Anabolic Steroid Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Androgen and Anabolic Steroid Revenue Market Share Forecast by Application (2023-2028)

Table 94. Auxilium Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 95. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Product Offered

Table 96. Auxilium Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Auxilium Pharmaceuticals Main Business

Table 98. Auxilium Pharmaceuticals Latest Developments

Table 99. AbbVie Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 100. AbbVie Androgen and Anabolic Steroid Product Offered

Table 101. AbbVie Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. AbbVie Main Business

Table 103. AbbVie Latest Developments

Table 104. Teva Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 105. Teva Androgen and Anabolic Steroid Product Offered

Table 106. Teva Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Teva Main Business

Table 108. Teva Latest Developments

Table 109. GlaxoSmithKline Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 110. GlaxoSmithKline Androgen and Anabolic Steroid Product Offered

Table 111. GlaxoSmithKline Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. GlaxoSmithKline Main Business

Table 113. GlaxoSmithKline Latest Developments

Table 114. Endo Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 115. Endo Pharmaceuticals Androgen and Anabolic Steroid Product Offered

Table 116. Endo Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Endo Pharmaceuticals Main Business

Table 118. Endo Pharmaceuticals Latest Developments

Table 119. Pfizer Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 120. Pfizer Androgen and Anabolic Steroid Product Offered

Table 121. Pfizer Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Pfizer Main Business

Table 123. Pfizer Latest Developments

Table 124. Acerus Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 125. Acerus Pharmaceuticals Androgen and Anabolic Steroid Product Offered

Table 126. Acerus Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Acerus Pharmaceuticals Main Business

Table 128. Acerus Pharmaceuticals Latest Developments

Table 129. Antares Pharma Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 130. Antares Pharma Androgen and Anabolic Steroid Product Offered

Table 131. Antares Pharma Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Antares Pharma Main Business

Table 133. Antares Pharma Latest Developments

Table 134. Amneal Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 135. Amneal Pharmaceuticals Androgen and Anabolic Steroid Product Offered

Table 136. Amneal Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Amneal Pharmaceuticals Main Business

Table 138. Amneal Pharmaceuticals Latest Developments

Table 139. Solvay Pharmaceuticals Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 140. Solvay Pharmaceuticals Androgen and Anabolic Steroid Product Offered

Table 141. Solvay Pharmaceuticals Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Solvay Pharmaceuticals Main Business

Table 143. Solvay Pharmaceuticals Latest Developments

Table 144. Bausch Health Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 145. Bausch Health Androgen and Anabolic Steroid Product Offered

Table 146. Bausch Health Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Bausch Health Main Business

Table 148. Bausch Health Latest Developments

Table 149. Pharmacia and Upjohn Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 150. Pharmacia and Upjohn Androgen and Anabolic Steroid Product Offered

Table 151. Pharmacia and Upjohn Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Pharmacia and Upjohn Main Business

Table 153. Pharmacia and Upjohn Latest Developments

Table 154. Upsher-Smith Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 155. Upsher-Smith Androgen and Anabolic Steroid Product Offered

Table 156. Upsher-Smith Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Upsher-Smith Main Business

Table 158. Upsher-Smith Latest Developments

Table 159. Clarus Therapeutics Basic Information, Androgen and Anabolic Steroid Manufacturing Base, Sales Area and Its Competitors

Table 160. Clarus Therapeutics Androgen and Anabolic Steroid Product Offered

Table 161. Clarus Therapeutics Androgen and Anabolic Steroid Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Clarus Therapeutics Main Business

Table 163. Clarus Therapeutics Latest Developments

List of Figures

Figure 1. Picture of Androgen and Anabolic Steroid

Figure 2. Androgen and Anabolic Steroid Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Androgen and Anabolic Steroid Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Androgen and Anabolic Steroid Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Androgen and Anabolic Steroid Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Testosterone

Figure 10. Product Picture of Methyltestosterone

Figure 11. Product Picture of Fluoxymesterone

Figure 12. Product Picture of Others

Figure 13. Global Androgen and Anabolic Steroid Sales Market Share by Type in 2021

Figure 14. Global Androgen and Anabolic Steroid Revenue Market Share by Type (2017-2022)

Figure 15. Androgen and Anabolic Steroid Consumed in Hospitals

Figure 16. Global Androgen and Anabolic Steroid Market: Hospitals (2017-2022) & (K Units)

Figure 17. Androgen and Anabolic Steroid Consumed in Pharmacy

Figure 18. Global Androgen and Anabolic Steroid Market: Pharmacy (2017-2022) & (K Units)

Figure 19. Androgen and Anabolic Steroid Consumed in Others

Figure 20. Global Androgen and Anabolic Steroid Market: Others (2017-2022) & (K Units)

Figure 21. Global Androgen and Anabolic Steroid Sales Market Share by Application (2017-2022)

Figure 22. Global Androgen and Anabolic Steroid Revenue Market Share by Application in 2021

Figure 23. Androgen and Anabolic Steroid Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Androgen and Anabolic Steroid Revenue Market Share by Company in 2021

Figure 25. Global Androgen and Anabolic Steroid Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Androgen and Anabolic Steroid Revenue Market Share by Geographic Region in 2021

Figure 27. Global Androgen and Anabolic Steroid Sales Market Share by Region (2017-2022)

Figure 28. Global Androgen and Anabolic Steroid Revenue Market Share by Country/Region in 2021

Figure 29. Americas Androgen and Anabolic Steroid Sales 2017-2022 (K Units)

Figure 30. Americas Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)

Figure 31. APAC Androgen and Anabolic Steroid Sales 2017-2022 (K Units)

Figure 32. APAC Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)

Figure 33. Europe Androgen and Anabolic Steroid Sales 2017-2022 (K Units)

Figure 34. Europe Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Androgen and Anabolic Steroid Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Androgen and Anabolic Steroid Revenue 2017-2022 ($ Millions)

Figure 37. Americas Androgen and Anabolic Steroid Sales Market Share by Country in 2021

Figure 38. Americas Androgen and Anabolic Steroid Revenue Market Share by Country in 2021

Figure 39. United States Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Androgen and Anabolic Steroid Sales Market Share by Region in 2021

Figure 44. APAC Androgen and Anabolic Steroid Revenue Market Share by Regions in 2021

Figure 45. China Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Androgen and Anabolic Steroid Sales Market Share by Country in 2021

Figure 52. Europe Androgen and Anabolic Steroid Revenue Market Share by Country in 2021

Figure 53. Germany Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Androgen and Anabolic Steroid Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Androgen and Anabolic Steroid Revenue Market Share by Country in 2021

Figure 60. Egypt Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Androgen and Anabolic Steroid Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Androgen and Anabolic Steroid in 2021

Figure 66. Manufacturing Process Analysis of Androgen and Anabolic Steroid

Figure 67. Industry Chain Structure of Androgen and Anabolic Steroid

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390